tiprankstipranks
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market
INM
InMed Pharmaceuticals
RESEARCH TOOLSreports
Want to see INM full AI Analyst Report?

InMed Pharmaceuticals (INM) Ratios

393 Followers

InMed Pharmaceuticals Ratios

INM's free cash flow for Q3 2026 was
gt;-0.01. For the 2026 fiscal year, INM's free cash flow was decreased by $ and operating cash flow was
gt;-0.01. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 3.11 6.99 4.41 5.66 2.89
Quick Ratio
 3.11 6.47 3.78 4.86 2.14
Cash Ratio
 2.33 6.02 3.33 4.45 1.86
Solvency Ratio
 -4.16 -2.61 -2.70 -3.65 -3.79
Operating Cash Flow Ratio
 -4.07 -3.10 -3.54 -3.64 -3.65
Short-Term Operating Cash Flow Coverage
 -23.13 0.00 0.00 0.00 0.00
Net Current Asset Value
$ 4.65M$ 14.61M$ 6.07M$ 9.32M$ 7.58M
Leverage Ratios
Debt-to-Assets Ratio
 0.05 0.05 0.08 0.03 0.06
Debt-to-Equity Ratio
 0.06 0.06 0.10 0.03 0.09
Debt-to-Capital Ratio
 0.06 0.05 0.09 0.03 0.08
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.33 1.16 1.28 1.17 1.41
Debt Service Coverage Ratio
 -22.92 -19.45 0.00 0.00 0.00
Interest Coverage Ratio
 -496.36 -21.22 0.00 0.00 0.00
Debt to Market Cap
 0.13 0.00 0.00 0.00 0.00
Interest Debt Per Share
 0.11 1.42 2.53 3.20 911.51
Net Debt to EBITDA
 0.51 1.94 0.79 1.09 0.52
Profitability Margins
Gross Profit Margin
0.16%34.53%23.94%33.93%49.89%
EBIT Margin
-1.50%-157.62%-166.79%-202.60%-1265.95%
EBITDA Margin
-1.41%-146.80%-153.64%-188.19%-1218.98%
Operating Profit Margin
-1.50%-160.20%-176.92%-202.60%-1265.95%
Pretax Profit Margin
-1.47%-165.14%-166.79%-191.86%-1707.32%
Net Profit Margin
-1.49%-165.14%-166.94%-192.18%-1707.32%
Continuous Operations Profit Margin
-1.47%-165.14%-166.94%-192.18%-1707.32%
Net Income Per EBT
101.79%100.00%100.09%100.17%100.00%
EBT Per EBIT
98.09%103.08%94.27%94.70%134.86%
Return on Assets (ROA)
-108.52%-38.45%-64.92%-56.34%-112.99%
Return on Equity (ROE)
-72.72%-44.59%-83.37%-65.74%-159.16%
Return on Capital Employed (ROCE)
-143.41%-42.30%-82.57%-69.21%-113.16%
Return on Invested Capital (ROIC)
-135.77%-41.00%-79.99%-67.13%-108.52%
Return on Tangible Assets
-129.82%-42.92%-76.45%-65.36%-135.31%
Earnings Yield
-142.36%-257.32%-400.46%-350.16%-7060.61%
Efficiency Ratios
Receivables Turnover
 0.00 7.80 13.03 15.88 9.61
Payables Turnover
 13.03 6.42 5.58 5.02 0.36
Inventory Turnover
 0.00 2.47 2.81 1.69 0.17
Fixed Asset Turnover
 1.03K 3.66 3.68 5.72 0.94
Asset Turnover
 72.68 0.23 0.39 0.29 0.07
Working Capital Turnover Ratio
 90.27 0.41 0.57 0.47 0.15
Cash Conversion Cycle
 -0.14 137.62 92.53 166.20 1.18K
Days of Sales Outstanding
 0.00 46.79 28.01 22.98 37.96
Days of Inventory Outstanding
 0.00 147.70 129.88 215.91 2.14K
Days of Payables Outstanding
 0.14 56.88 65.36 72.69 1.00K
Operating Cycle
 0.00 194.50 157.89 238.89 2.18K
Cash Flow Ratios
Operating Cash Flow Per Share
 -2.22 -7.96 -18.33 -59.49 -13.90K
Free Cash Flow Per Share
 -2.22 -7.96 -18.36 -60.81 -13.94K
CapEx Per Share
 <0.01 0.00 0.02 1.32 34.89
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
 -949.06K 0.00 -751.73 -45.01 -398.48
Capital Expenditure Coverage Ratio
 -949.06K 0.00 -751.73 -45.01 -398.48
Operating Cash Flow Coverage Ratio
 -21.44 -7.69 -7.26 -18.59 -15.25
Operating Cash Flow to Sales Ratio
 -0.01 -1.57 -1.52 -1.76 -14.30
Free Cash Flow Yield
-289.31%-244.86%-364.96%-328.02%-5930.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.68 -0.39 -0.25 -0.29 -0.01
Price-to-Sales (P/S) Ratio
 <0.01 0.64 0.42 0.55 0.24
Price-to-Book (P/B) Ratio
 0.98 0.17 0.21 0.19 0.02
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.33 -0.41 -0.27 -0.30 -0.02
Price-to-Operating Cash Flow Ratio
 -0.75 -0.41 -0.27 -0.31 -0.02
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 <0.01 <0.01 <0.01 >-0.01
Price-to-Fair Value
 0.98 0.17 0.21 0.19 0.02
Enterprise Value Multiple
 0.18 1.50 0.52 0.80 0.50
Enterprise Value
 -1.63M -10.91M -3.69M -6.25M -6.67M
EV to EBITDA
 0.17 1.50 0.52 0.80 0.50
EV to Sales
 >-0.01 -2.21 -0.80 -1.51 -6.12
EV to Free Cash Flow
 0.18 1.40 0.53 0.84 0.43
EV to Operating Cash Flow
 0.18 1.40 0.53 0.86 0.43
Tangible Book Value Per Share
 1.33 16.49 19.48 82.86 8.00K
Shareholders’ Equity Per Share
 1.70 18.75 24.16 98.75 10.43K
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 >-0.01 >-0.01 0.00
Revenue Per Share
 163.99 5.06 12.07 33.78 971.84
Net Income Per Share
 -2.45 -8.36 -20.14 -64.92 -16.59K
Tax Burden
 1.02 1.00 1.00 1.00 1.00
Interest Burden
 0.98 1.05 1.00 0.95 1.35
Research & Development to Revenue
 <0.01 0.58 0.70 0.90 6.68
SG&A to Revenue
 0.37 1.33 1.26 1.41 6.30
Stock-Based Compensation to Revenue
 0.07 0.02 0.03 0.07 0.64
Income Quality
 <0.01 0.95 0.91 0.92 0.84
Currency in USD